SF3B1 and myelodysplastic syndrome: This study demonstrates that SF3B1 mutations can originate in rare CD34+CD38−CD90+CD49f+ HSCs, and MDS-ICs are restricted to these rare HSC fractions in our cohort of MDS patients with ring sideroblasts.